Tower Research Capital (TRC)’s UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In MLPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-100
Closed -$2K 5350
2016
Q1
$2K Buy
100
+21
+27% +$350 ﹤0.01% 3544
2015
Q4
$1K Buy
+79
New +$1.14K ﹤0.01% 4280

Tower Research Capital (TRC)'s MLPS Position: Q2 2016 in Review

Tower Research Capital (TRC) sold out of UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In (MLPS) in Q2 2016, closing a stake of 100 shares — an estimated $2K sold.

Tower Research Capital (TRC) first reported a position in MLPS in Q4 2015 and held it in 2 quarters. The position peaked at $2K in Q1 2016. 1 fund tracked by Wall St. Rank holds MLPS as of Q2 2016.

  • Tower Research Capital (TRC) reported no remaining UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In position as of Q2 2016 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 100 UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In shares in Q2 2016, an estimated $2K.
  • Tower Research Capital (TRC) first reported a position in UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In in Q4 2015 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In position peaked at $2K in Q1 2016.
  • 1 fund tracked by Wall St. Rank held UBS AG 1xMonthly Short Exchange Traded Access Securities (E-TRACS) Linked to the Alerian MLP In as of Q2 2016.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2016, filed 10 Aug 2016.